» Articles » PMID: 37204387

Refining the Prognostic Value of LGE In Hypertrophic Cardiomyopathy: Presence, Extent, and Location-What's Next?

Overview
Publisher Elsevier
Date 2023 May 19
PMID 37204387
Authors
Affiliations
Soon will be listed here.
Citing Articles

[Clincial Research Progress in Using Magnetic Resonance Imaging to Assess Myocardial Fibrosis in Hypertrophic Cardiomyopathy].

Shi K, Yu S, Xia D, Guo Y, Yang Z Sichuan Da Xue Xue Bao Yi Xue Ban. 2025; 55(6):1357-1363.

PMID: 39990836 PMC: 11839347. DOI: 10.12182/20241160601.


Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy.

Verheyen N, Auer J, Bonaros N, Buchacher T, Dalos D, Grimm M Wien Klin Wochenschr. 2024; 136(Suppl 15):571-597.

PMID: 39352517 PMC: 11445290. DOI: 10.1007/s00508-024-02442-1.


Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy.

Zhi Y, Gui F, Xue M, Long Y, Miao W, Yi Y BMC Cardiovasc Disord. 2024; 24(1):203.

PMID: 38594610 PMC: 11003119. DOI: 10.1186/s12872-024-03859-2.


Fractal analysis in cardiovascular magnetic resonance: prognostic value of biventricular trabecular complexity in hypertrophic cardiomyopathy.

Jiang W, Chen B, Zhang C, Shi R, Wu R, An D Cardiovasc Diagn Ther. 2024; 13(6):1030-1042.

PMID: 38162100 PMC: 10753232. DOI: 10.21037/cdt-23-162.


The Presence, Location, and Degree of Late Gadolinium Enhancement in Relation to Myocardial Dysfunction and Poor Prognosis in Patients with Systemic Lupus Erythematosus.

Feng X, Liu P, Liu X, Guo T, Li X, Yang H J Cardiovasc Dev Dis. 2023; 10(11).

PMID: 37998509 PMC: 10672496. DOI: 10.3390/jcdd10110451.